Nutex Health Appoints New Chief Operating Officer

Clinigence Holdings ( (NUTX) ) has issued an update.

On September 22, 2025, Nutex Health Inc. announced the appointment of Wesley Bamburg as the new Chief Operating Officer, effective October 13, 2025. Bamburg, with 20 years of experience in healthcare operations and management, is expected to contribute significantly to Nutex Health’s growth and expansion. His expertise in operations, payor contracting, and physician relations will be pivotal as the company continues to strengthen its healthcare delivery model and expand its national presence.

The most recent analyst rating on (NUTX) stock is a Buy with a $99.00 price target. To see the full list of analyst forecasts on Clinigence Holdings stock, see the NUTX Stock Forecast page.

Spark’s Take on NUTX Stock

According to Spark, TipRanks’ AI Analyst, NUTX is a Outperform.

NUTX demonstrates strong financial performance with notable revenue growth and profitability improvements. The stock’s low P/E ratio suggests it is undervalued, offering potential for price appreciation. However, technical indicators present mixed signals, and concerns over financial leverage and reliance on arbitration revenue warrant cautious optimism.

To see Spark’s full report on NUTX stock, click here.

More about Clinigence Holdings

Nutex Health Inc., headquartered in Houston, Texas, is a healthcare management and operations company founded in 2011. It operates through two divisions: the Hospital Division, which owns and operates micro-hospitals, specialty hospitals, and hospital outpatient departments across 11 states, and the Population Health Management Division, which manages provider networks and offers management services to affiliated hospitals and physician groups.

Average Trading Volume: 253,079

Technical Sentiment Signal: Hold

Current Market Cap: $533.9M

Learn more about NUTX stock on TipRanks’ Stock Analysis page.